Company intelligence / Profile preview

Penn Pharmaceutical Services

Tredegar, Wales, United Kingdom

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Penn Pharmaceutical Services, now a key part of PCI Pharma Services, is a specialist contract development and manufacturing organization (CDMO) based in the United Kingdom. The company provides a comprehensive range of services including formulation development, analytical chemistry, clinical trial supply, and commercial manufacturing. They are particularly renowned for their expertise in handling highly potent drug substances and developing complex solid oral dosage forms. Following its acquisition by PCI in 2014, the company's Tredegar facility has become a global center of excellence for drug development and contained manufacturing within the larger PCI network.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Penn Pharmaceutical Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penn Pharmaceutical Services.

Explore the full profile